Swiss Re Net Profit Surged on Property-and-Casualty Strength
By Adria Calatayud
Swiss Re reported a sharply higher net profit for last year thanks to an improved performance in its property-and-casualty reinsurance segment, where large natural-catastrophe claims were below budget.
The Zurich-based reinsurer said Friday that it made a net profit of $3.21 billion compared with $472 million in 2022. It targeted a profit of more than $3 billion in 2023, while analysts polled by FactSet had forecast $3.27 billion.
Swiss Re's property-and-casualty segment was the largest profit contributor with $1.86 billion, while its life-and-health and corporate-solutions businesses also posted higher profits.
Large natural-catastrophe claims amounted to $1.3 billion last year, below the budget of $1.7 billion, the company said.
Net premiums earned and fee income rose to $45.00 billion from $43.12 billion.
Swiss Re said it renewed treaty contracts valued at $13.1 billion on Jan. 1, representing a 9% volume increase compared with the business that was up for renewal and achieving a price rise of 9%.
Swiss Re maintained its profit target for 2024 of more than $3.6 billion.
Its board proposed a dividend of $6.80 a share for 2023, up 6% on the prior year.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
February 16, 2024 01:39 ET (06:39 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
For Bond Investors, Delayed Rate Cuts Demand a Different Playbook
-
What’s Happening In the Markets This Week
-
How the Tokyo Stock Exchange Is Pushing for Better Shareholder Returns
-
Magnificent 7 Stocks Earnings Updates: AI Remains the Focus
-
Where We See Opportunities After an Ugly Month for Stocks
-
After Earnings, Is Alphabet Stock a Buy, a Sell, or Fairly Valued?
-
When Will the Fed Start Cutting Interest Rates?
-
What’s the Difference Between the CPI and PCE Indexes?
-
10 Questions for Berkshire Hathaway’s 2024 Annual Meeting
-
After Earnings, Is Ford Stock a Buy, a Sell, or Fairly Valued?
-
3 Dividend Stocks for May 2024
-
Amgen Earnings: Obesity Drug Update Is Highly Encouraging
-
What’s Going on With Apple, Tesla, and Alphabet?
-
Apple Earnings: A Weak 2024, but Optimism for 2025
-
4 Utility Stocks to Play the AI Data Center Boom
-
Albemarle Earnings: We Expect Improved Results In the Rest of Year Following Cyclically Low Profits